Elekta AB (publ)
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa … Read more
Market Cap & Net Worth: Elekta AB (publ) (EKTAF)
Elekta AB (publ) (PINK:EKTAF) has a market capitalization of $2.09 Billion ($2.09 Billion) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #5252 globally and #3118 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Elekta AB (publ)'s stock price $5.69 by its total outstanding shares 367102351 (367.10 Million).
Elekta AB (publ) Market Cap History: 2015 to 2025
Elekta AB (publ)'s market capitalization history from 2015 to 2025. Data shows change from $2.16 Billion to $2.09 Billion (-0.09% CAGR).
Elekta AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Elekta AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.12x
Elekta AB (publ)'s market cap is 0.12 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
8.81x
Elekta AB (publ)'s market cap is 8.81 times its annual earnings
1.94x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.37 Billion | $11.22 Billion | $137.00 Million | 0.21x | 17.30x |
| 2017 | $2.39 Billion | $10.70 Billion | $125.00 Million | 0.22x | 19.12x |
| 2018 | $3.58 Billion | $11.57 Billion | $1.35 Billion | 0.31x | 2.65x |
| 2019 | $4.34 Billion | $13.55 Billion | $1.20 Billion | 0.32x | 3.63x |
| 2020 | $4.38 Billion | $14.60 Billion | $1.08 Billion | 0.30x | 4.04x |
| 2021 | $4.53 Billion | $13.76 Billion | $1.25 Billion | 0.33x | 3.61x |
| 2022 | $2.22 Billion | $14.55 Billion | $1.15 Billion | 0.15x | 1.93x |
| 2023 | $2.99 Billion | $16.87 Billion | $943.00 Million | 0.18x | 3.17x |
| 2024 | $2.16 Billion | $18.12 Billion | $1.30 Billion | 0.12x | 1.66x |
| 2025 | $2.09 Billion | $18.02 Billion | $237.00 Million | 0.12x | 8.81x |
Competitor Companies of EKTAF by Market Capitalization
Companies near Elekta AB (publ) in the global market cap rankings as of March 19, 2026.
Key companies related to Elekta AB (publ) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
Elekta AB (publ) Historical Marketcap From 2015 to 2025
Between 2015 and today, Elekta AB (publ)'s market cap moved from $2.16 Billion to $ 2.09 Billion, with a yearly change of -0.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.09 Billion | -3.48% |
| 2024 | $2.16 Billion | -27.65% |
| 2023 | $2.99 Billion | +34.64% |
| 2022 | $2.22 Billion | -50.92% |
| 2021 | $4.53 Billion | +3.23% |
| 2020 | $4.38 Billion | +0.94% |
| 2019 | $4.34 Billion | +21.42% |
| 2018 | $3.58 Billion | +49.71% |
| 2017 | $2.39 Billion | +0.80% |
| 2016 | $2.37 Billion | +9.78% |
| 2015 | $2.16 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Elekta AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.09 Billion USD |
| MoneyControl | $2.09 Billion USD |
| MarketWatch | $2.09 Billion USD |
| marketcap.company | $2.09 Billion USD |
| Reuters | $2.09 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.